Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented Epithelium

Dry age-related macular degeneration (AMD) is estimated to impact nearly 300 million individuals globally by 2040. While no treatment options are currently available, multiple clinical trials investigating retinal pigmented epithelial cells derived from human pluripotent stem cells (hPSC-RPE) as a c...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Mohamed A. Faynus, Jeffrey K. Bailey, Britney O. Pennington, Mika Katsura, Duncan A. Proctor, Ashley K. Yeh, Sneha Menon, Dylan G. Choi, Jane S. Lebkowski, Lincoln V. Johnson, Dennis O. Clegg
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-07-01
סדרה:	Bioengineering
נושאים:	microcarriers stem cells retinal pigment epithelium
גישה מקוונת:	https://www.mdpi.com/2306-5354/9/7/297
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!